Transfeminine people reported the greatest willingness to try on-demand pre-exposure prophylaxis (PrEP) when asked about their willingness to start one of three PrEP options—daily oral (DO), on-demand, and long-acting injectable (LAPrEP)—as well as their preferences between these options, according to findings published in PLOS One. “PrEP usage prevalence among transfeminine persons is estimated to be […]
The post Offering Multiple PrEP Options Could Increase Uptake Among Transfeminine People first appeared on Physician’s Weekly.
